Ablative laser or chemical peels can help improve the lower lid rhytides in patients that undergo a transconjunctival blepharoplasty. Ablative procedures are generally reserved for patients with Fitzpatrick skin type III or lower, and caution is used in those with type IV skin or higher because of increased risks of pigmentary changes. Pretreatment with a 4- to 6-week nightly regimen of topical retinoin (0.05% to 0.10%), hydroquinone (4% to 8%), and alpha hydroxyl acid (4% to 10%) up until 1 week before treatment is recommended.
Trichloroacetic acid ranging from 20% to 35% provides a satisfactory result in patients with mild rhytides.63,64 Facial ablative resurfacing with lasers is performed typically with carbon dioxide and erbium:yttrium-aluminum-garnet lasers.64 Traditional ablative platforms are very effective but carry a risk for prolonged healing time, erythema, edema, and risk of hypopigmentation. In contrast, fractionated ablative platforms can help lead to faster reepithelialization and thus quicker healing times.65
Lid tone should be evaluated in every patient. There is invariably some element of lid laxity in most elderly patients. Caution should be exercised with skin excision when a poor snap-back test or distraction of greater than 6 mm of lid from the globe is found. Conservative excisions, particularly medially, should be performed in such cases. A concomitant lid resuspension technique such as canthopexy should also be considered in cases with mild to moderate lid laxity, particularly when performing any skin removal.15 Canthopexy procedures can be performed either through an open lateral canthal incision or through an upper lid crease incision. In both techniques, the lateral canthal tendon is grasped and secured to the Whitnall tubercle inside the orbital rim, at the appropriate vertical height for adequate resuspension. However, a canthopexy does not shorten the lower lid. In contrast, tarsal strip canthoplasty is a lid-shortening technique and should be reserved for cases with severe lid laxity (i.e., >6-mm distraction, poor snap-back test) and/or preoperative ectropion.35,66
The transconjunctival incision allows the surgeon direct access to the lower lid fat compartments. The incision is typically 4 to 6 mm below the inferior tarsal plate to detach the lower lid retractors away from the inferior tarsal plate. The incision spans the puncta medially and just adjacent to the lateral canthus laterally.
The three orbital fat pads are identified through a postseptal or preseptal approach, medial first, followed by central, then lateral. If fat repositioning is going to be performed, both the medial and central fat compartments are typically repositioned and the lateral fat compartment is debulked to the level of the orbital rim (Fig. 12). The lateral aspect of the infraorbital rim has been shown to be rejuvenated best with autologous fat grafting and/or postoperative synthetic subdermal fillers as opposed to redraping techniques.48
Once an adequate amount of fat has been prepared for repositioning, dissection is performed along the orbital rim through a subperiosteal or supraperiosteal approach (Fig. 12). The authors prefer externalizing a percutaneous suture that secures the fat pedicles subperiosteally using a 5-0 polypropylene suture both medial and lateral to the infraorbital nerve (Figs. 13 through 15). Other authors have described repositioning using buried, absorbable sutures.47,67,68 The sutures are tied over a bolster and removed on postoperative day 6. Our preferred technique is shown in our accompanying video. (See Video, Supplemental Digital Content 2, which demonstrates the essential steps involved in performing an upper lid blepharoplasty and a lower lid transconjunctival blepharoplasty with lower lid fat repositioning and application of 30% trichloroacetic acid. This video is available in the “Related Videos” section of the full-text article on PRSJournal.com or at http://links.lww.com/PRS/B532.)
Although there exists several variations to the technique, the skin-muscle flap blepharoplasty has been well-described by Codner et al.35 In summary, the surgeon first elevates a skin-muscle flap through a subciliary incision while preserving 3 to 4 mm of underlying pretarsal orbicularis muscle. The preseptal portion of the orbicularis muscle is included in the skin-muscle flap, which is carefully created inferiorly toward the infraorbital rim. A selective release of the orbicularis retaining ligament supraperiosteally can be performed to help improve the appearance of the lid-cheek junction. Herniated orbital fat is visualized through septal incisions, and the fat pads are either debulked and/or repositioned along the infraorbital rim subperiosteally with or without a septal reset procedure as described above. To help preserve orbicularis innervation, the lateral dissection should not go past the lateral orbital rim. A lateral canthopexy is then performed as mentioned previously.15,35,69 The skin muscle flap is then elevated in a superotemporal direction and trimmed as needed. The orbicularis is then resuspended along the lateral orbital rim. Excess skin is then excised conservatively and the incision is closed carefully.
Patients are instructed to use ice-water–soaked gauze or cool packs to the affected area for the first 72 hours to minimize swelling. Severe pain is unusual following a blepharoplasty, and patients should be evaluated immediately in the office to rule out retrobulbar hematoma in cases of severe pain and/or vision changes. Head position is usually maintained at or above the heart level to reduce edema. An antibiotic ophthalmic ointment (i.e., erythromycin) is often applied to the upper lids two times per day for the first week. Antibiotic drops with or without a steroid component four times per day for the first week are used in cases where a conjunctival incision is made. Patients are instructed to refrain from any strenuous activity for the first 10 to 14 days. Sutures are removed, usually on postoperative days 5 to 7. Patients are advised that most of the swelling persists for 2 weeks after surgery but that residual swelling, which at times can be asymmetric, may last up to 3 to 6 months.
Complications associated with blepharoplasty should be well understood by the surgeon. Lelli and Lisman provide a comprehensive review of the complications and categorize them into early, intermediate, and late phases.70 The most feared early complication is orbital hemorrhage, which must be identified and treated immediately, as this can result in permanent vision loss and even blindness. If vision is threatened, treatment should involve an immediate ophthalmologic consultation and medical and/or surgical treatment. Medical treatment may include intraocular pressure–reducing medications, and surgical treatment may include exploration of the wound and/or lateral canthotomy/cantholysis to help reduce orbital pressure.71,72 Infections following blepharoplasty, albeit rare, can occur and should be assessed and treated appropriately with antibiotics.73
Intermediate- and long-term complications include dry eyes, lower lid malposition, lagophthalmos, and ptosis. Many of these complications can often be avoided with careful preoperative planning and appropriate surgical technique. Intermediate- and long-term complications can be very difficult to manage, often requiring surgical revision for treatment, and therefore every attempt to avoid such complications with proper planning and execution should be made. Dry eyes should be assessed preoperatively and optimized before the patient undergoes any blepharoplasty procedure. Iatrogenic ptosis should be avoided by taking care to preserve levator attachments to the tarsal plate by avoiding excessively deep dissection directly onto the tarsal plate during an upper lid blepharoplasty. Lagophthalmos often involves overzealous skin excision, particularly when performed in conjunction with a brow lift. Conservative markings and using measurements as a guideline as mentioned above should help avoid such complications. Lid malposition is one of the more feared complications of the lower lid and frequently requires surgical management. On first indication of lid retraction, lid massaging and Carraway exercises should be instituted as soon as possible.74 Injection of wound modulators such as triamcinolone and/or 5-fluorouracil has been used in attempts to minimize scar formation and retraction. Although they have a long record of safety, efficacy, and mechanistic understanding, the use of such wound modulators is an off-label use, and adequate patient counseling should be performed before their administration.75–78 If conservative treatments have failed, surgical revision should be considered.
Recent literature has supported volume preservation with both upper and lower lid blepharoplasty. Such advancements have enabled patients to undergo a procedure that rejuvenates their eyelids and maintains a more natural appearance to the periorbita. Careful preoperative planning should be performed to determine an optimal approach for each patient. The surgeon should be aware of the anatomical changes that occur in the aging eyelid, and the use of premorbid photographs can help clarify such changes and the goal for rejuvenation. An algorithmic approach is useful in determining the appropriate surgical plan. Through careful preoperative evaluation and sound surgical planning, the surgeon can reduce the risks of complications and deliver a consistent and predictable result.
The patient provided written consent for the use of his image.
2. Codner MA, Kikkawa DO, Korn BS, Pacella SJ. Blepharoplasty and brow lift. Plast Reconstr Surg. 2010;126:1e–17e
3. Knize DM. Anatomic concepts for brow lift procedures. Plast Reconstr Surg. 2009;124:2118–2126
4. Matarasso A, Hutchinson OH. Evaluating rejuvenation of the forehead and brow: An algorithm for selecting the appropriate technique. Plast Reconstr Surg. 2000;106:687–694 discussion 695–696.
5. McCord CD, Doxanas MT. Browplasty and browpexy: An adjunct to blepharoplasty. Plast Reconstr Surg. 1990;86:248–254
6. Romo T III, Zoumalan RA, Rafii BY. Current concepts in the management of the aging forehead in facial plastic surgery. Curr Opin Otolaryngol Head Neck Surg. 2010;18:272–277
7. Rohrich RJ, Arbique GM, Wong C, Brown S, Pessa JE. The anatomy of suborbicularis fat: Implications for periorbital rejuvenation. Plast Reconstr Surg. 2009;124:946–951
8. Rohrich RJ, Pessa JE. The fat compartments of the face: Anatomy and clinical implications for cosmetic surgery. Plast Reconstr Surg. 2007;119:2219–2227 discussion 2228–2231.
9. Mendelson BC, Jacobson SR. Surgical anatomy of the midcheek: Facial layers, spaces, and the midcheek segments. Clin Plast Surg. 2008;35:395–404; discussion 393.
10. Moss CJ, Mendelson BC, Taylor GI. Surgical anatomy of the ligamentous attachments in the temple and periorbital regions. Plast Reconstr Surg. 2000;105:1475–1490; discussion 1491.
11. Jelks GW, Jelks EB. The influence of orbital and eyelid anatomy on the palpebral aperture. Clin Plast Surg. 1991;18:183–195
12. Damasceno RW, Cariello AJ, Cardoso EB, Viana GA, Osaki MH. Upper blepharoplasty with or without resection of the orbicularis oculi muscle: A randomized double-blind left-right study. Ophthal Plast Reconstr Surg. 2011;27:195–197
13. Fagien S. The role of the orbicularis oculi muscle and the eyelid crease in optimizing results in aesthetic upper blepharoplasty: A new look at the surgical treatment of mild upper eyelid fissure and fold asymmetries. Plast Reconstr Surg. 2010;125:653–666
14. Oh SR, Chokthaweesak W, Annunziata CC, Priel A, Korn BS, Kikkawa DO. Analysis of eyelid fat pad changes with aging. Ophthal Plast Reconstr Surg. 2011;27:348–351
15. Fagien S. Algorithm for canthoplasty: The lateral retinacular suspension. A simplified suture canthopexy. Plast Reconstr Surg. 1999;103:2042–2053 discussion 2054–2058.
16. Flowers RS. Canthopexy as a routine blepharoplasty component. Clin Plast Surg. 1993;20:351–365
17. Lisman RD, Rees T, Baker D, Smith B. Experience with tarsal suspension as a factor in lower lid blepharoplasty. Plast Reconstr Surg. 1987;79:897–905
18. Graham DW, Heller J, Kurkjian TJ, Kirkjian TJ, Schaub TS, Rohrich RJ. Brow lift in facial rejuvenation: A systematic literature review of open versus endoscopic techniques. Plast Reconstr Surg. 2011;128:335e–341e
19. Drolet BC, Phillips BZ, Hoy EA, Chang J, Sullivan PK. Finesse in forehead and brow rejuvenation: Modern concepts, including endoscopic methods. Plast Reconstr Surg. 2014;134:1141–1150
20. Chiu ES, Baker DC. Endoscopic brow lift: A retrospective review of 628 consecutive cases over 5 years. Plast Reconstr Surg. 2003;112:628–633; discussion 634.
21. Collar RM, Boahene KD, Byrne PJ. Adjunctive fat grafting to the upper lid and brow. Clin Plast Surg. 2013;40:191–199
22. Friedland JA, Lalonde DH, Rohrich RJ. An evidence-based approach to blepharoplasty. Plast Reconstr Surg. 2010;126:2222–2229
23. Drolet BC, Sullivan PK. Evidence-based medicine: Blepharoplasty. Plast Reconstr Surg. 2014;133:1195–1205
24. Chang S, Lehrman C, Itani K, Rohrich RJ. A systematic review of comparison of upper eyelid involutional ptosis repair techniques: Efficacy and complication rates. Plast Reconstr Surg. 2012;129:149–157
25. Zoumalan CI, Lisman RD. Evaluation and management of unilateral ptosis and avoiding contralateral ptosis. Aesthet Surg J. 2010;30:320–328
26. Rees TD, Jelks GW. Blepharoplasty and the dry eye syndrome: Guidelines for surgery? Plast Reconstr Surg. 1981;68:249–252
27. Hamawy AH, Farkas JP, Fagien S, Rohrich RJ. Preventing and managing dry eyes after periorbital surgery: A retrospective review. Plast Reconstr Surg. 2009;123:353–359
28. Fagien S. Reducing the incidence of dry eye symptoms after blepharoplasty. Aesthet Surg J. 2004;24:464–468
29. Lee WB, McCord CD Jr, Somia N, Hirmand H. Optimizing blepharoplasty outcomes in patients with previous laser vision correction. Plast Reconstr Surg. 2008;122:587–594
30. Beare RSmith B, Converse JM. Surgical treatment of senile changes in the eyelids: The McIndoe-Beare technique. Proceedings of the Second International Symposium on Plastic and Reconstructive Surgery of the Eye and Adnexa. 1967 St. Louis Mosby:362–366
31. Castanares S. Blepharoplasty for herniated intraorbital fat; anatomical basis for a new approach. Plast Reconstr Surg (1946). 1951;8:46–58
32. Carraway JH, Mellow CG. The prevention and treatment of lower lid ectropion following blepharoplasty. Plast Reconstr Surg. 1990;85:971–981
33. McCord CD Jr, Shore JW. Avoidance of complications in lower lid blepharoplasty. Ophthalmology. 1983;90:1039–1046
34. Rees TD. Prevention of ectropion by horizontal shortening of the lower lid during blepharoplasty. Ann Plast Surg. 1983;11:17–23
35. Codner MA, Wolfli JN, Anzarut A. Primary transcutaneous lower blepharoplasty with routine lateral canthal support: A comprehensive 10-year review. Plast Reconstr Surg. 2008;121:241–250
36. Tomlinson FB, Hovey LM. Transconjunctival lower lid blepharoplasty for removal of fat. Plast Reconstr Surg. 1975;56:314–318
37. Zarem HA, Resnick JI. Expanded applications for transconjunctival lower lid blepharoplasty. Plast Reconstr Surg. 1991;88:215–220; discussion 221.
38. Zarem HA, Resnick JI. Expanded applications for transconjunctival lower lid blepharoplasty. Plast Reconstr Surg. 1999;103:1041–1043; discussion 1044.
39. Baylis HI, Long JA, Groth MJ. Transconjunctival lower eyelid blepharoplasty: Technique and complications. Ophthalmology. 1989;96:1027–1032
40. Loeb R. Naso-jugal groove leveling with fat tissue. Clin Plast Surg. 1993;20:393–400; discussion 401.
41. Loeb R. Fat pad sliding and fat grafting for leveling lid depressions. Clin Plast Surg. 1981;8:757–776
42. Hamra ST. Arcus marginalis release and orbital fat preservation in midface rejuvenation. Plast Reconstr Surg. 1995;96:354–362
43. Hamra ST. The role of orbital fat preservation in facial aesthetic surgery: A new concept. Clin Plast Surg. 1996;23:17–28
44. Barton FE Jr, Ha R, Awada M. Fat extrusion and septal reset in patients with the tear trough triad: A critical appraisal. Plast Reconstr Surg. 2004;113:2115–2121; discussion 2122.
45. Goldberg RA. Transconjunctival orbital fat repositioning: Transposition of orbital fat pedicles into a subperiosteal pocket. Plast Reconstr Surg. 2000;105:743–748 discussion 749–751.
46. Yoo DB, Peng GL, Massry GG. Transconjunctival lower blepharoplasty with fat repositioning: A retrospective comparison of transposing fat to the subperiosteal vs supraperiosteal planes. JAMA Facial Plast Surg. 2013;15:176–181
47. Kawamoto HK, Bradley JP. The tear “TROUF” procedure: Transconjunctival repositioning of orbital unipedicled fat. Plast Reconstr Surg. 2003;112:1903–1907; discussion 1908.
48. Rohrich RJ, Ghavami A, Mojallal A. The five-step lower blepharoplasty: Blending the eyelid-cheek junction. Plast Reconstr Surg. 2011;128:775–783
49. Einan-Lifshitz A, Holds JB, Wulc AE, Hartstein ME. Volumetric rejuvenation of the tear trough with repo and Ristow. Ophthal Plast Reconstr Surg. 2013;29:481–485
50. Collar RM, Lyford-Pike S, Byrne P. Algorithmic approach to lower lid blepharoplasty. Facial Plast Surg. 2013;29:32–39
51. Darcy SJ, Miller TA, Goldberg RA, Villablanca JP, Demer JL, Rudkin GH. Magnetic resonance imaging characterization of orbital changes with age and associated contributions to lower eyelid prominence. Plast Reconstr Surg. 2008;122:921–929; discussion 930.
52. Chen YS, Tsai TH, Wu ML, Chang KC, Lin TW. Evaluation of age-related intraorbital fat herniation through computed tomography. Plast Reconstr Surg. 2008;122:1191–1198
53. Youn S, Shin JI, Kim JT, Kim YH. Transconjunctival subperiosteal fat reposition for tear trough deformity: Pedicled fat redraping versus septal reset. Ann Plast Surg. 2014;73:479–484
54. Haddock NT, Saadeh PB, Boutros S, Thorne CH. The tear trough and lid/cheek junction: Anatomy and implications for surgical correction. Plast Reconstr Surg. 2009;123:1332–1340; discussion 1341.
55. Lambros VS. Hyaluronic acid injections for correction of the tear trough deformity. Plast Reconstr Surg. 2007;120(Suppl):74S–80S
56. Morley AM, Malhotra R. Use of hyaluronic acid filler for tear-trough rejuvenation as an alternative to lower eyelid surgery. Ophthal Plast Reconstr Surg. 2011;27:69–73
57. Stutman RL, Codner MA. Tear trough deformity: Review of anatomy and treatment options. Aesthet Surg J. 2012;32:426–440
58. Jelks GW, Jelks EB. Preoperative evaluation of the blepharoplasty patient: Bypassing the pitfalls. Clin Plast Surg. 1993;20:213–223; discussion 224.
59. Zoumalan CI, Lattman J, Zoumalan RA, Rosenberg DB. Orbicularis suspension flap and its effect on lower eyelid position: A digital image analysis. Arch Facial Plast Surg. 2010;12:24–29
60. Trussler AP, Schaub TA, Byrd HS. Endoscopic management of the difficult lower eyelid: A review of 300 cases. Plast Reconstr Surg. 2012;130:690–699
61. Trussler AP, Byrd HS. Management of the midface during facial rejuvenation. Semin Plast Surg. 2009;23:274–282
62. Rosenfield LK. The pinch blepharoplasty revisited. Plast Reconstr Surg. 2005;115:1405–1412; discussion 1413.
63. Herbig K, Trussler AP, Khosla RK, Rohrich RJ. Combination Jessner’s solution and trichloroacetic acid chemical peel: Technique and outcomes. Plast Reconstr Surg. 2009;124:955–964
64. Roy D. Ablative facial resurfacing. Dermatol Clin. 2005;23:549–559, viii
65. Yates B, Que SK, D’Souza L, Suchecki J, Finch JJ. Laser treatment of periocular skin conditions. Clin Dermatol. 2015;33:197–206
66. Taban M, Nakra T, Hwang C, et al. Aesthetic lateral canthoplasty. Ophthal Plast Reconstr Surg. 2010;26:190–194
67. Sullivan PK, Drolet BC. Extended lower lid blepharoplasty for eyelid and midface rejuvenation. Plast Reconstr Surg. 2013;132:1093–1101
68. Hidalgo DA. An integrated approach to lower blepharoplasty. Plast Reconstr Surg. 2011;127:386–395
69. Jelks GW, Glat PM, Jelks EB, Longaker MT. The inferior retinacular lateral canthoplasty: A new technique. Plast Reconstr Surg. 1997;100:1262–1270 discussion 1271–1275.
70. Lelli GJ Jr, Lisman RD. Blepharoplasty complications. Plast Reconstr Surg. 2010;125:1007–1017
71. Zoumalan CI, Bullock JD, Warwar RE, Fuller B, McCulley TJ. Evaluation of intraocular and orbital pressure in the management of orbital hemorrhage: An experimental model. Arch Ophthalmol. 2008;126:1257–1260
72. Trussler AP, Rohrich RJ. MOC-PSSM CME article: Blepharoplasty. Plast Reconstr Surg. 2008;121(Suppl):1–10
73. Juthani V, Zoumalan CI, Lisman RD, Rizk SS. Successful management of methicillin-resistant
Staphylococcus aureus orbital cellulitis after blepharoplasty. Plast Reconstr Surg. 2010;126:305e–307e
74. Carraway JH, Mellow CG. The prevention and treatment of lower lid ectropion following blepharoplasty. Plast Reconstr Surg. 1990;85:971–981
75. Taban M, Lee S, Hoenig J, Mancini R, Goldberg R, Douglas RMassry G, Murphy MR, Azizzadeh B. Postoperative wound modulation in aesthetic eyelid and periorbital surgery. Master Techniques in Blepharoplasty and Periorbital Rejuvenation. 2011 New York Springer:307–312
76. Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg. 1999;25:224–232
77. Ledon JA, Savas J, Franca K, Chacon A, Nouri K. Intralesional treatment for keloids and hypertrophic scars: A review. Dermatol Surg. 2013;39:1745–1757
78. Gupta S, Kalra A. Efficacy and safety of intralesional 5-fluorouracil in the treatment of keloids. Dermatology. 2002;204:130–132